http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2787194-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ba67fbc9a4ca4141877aa8b5c0c515c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
filingDate 2011-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6ffca0846c5fa9c84048bba52c32185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3476e7db974f0855d4c6a09aaa300172
publicationDate 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2787194-C
titleOfInvention Set of probes for the detection and typing of 46 human papillomavirus mucosal types
abstract We have developed a set of probes to detect and identify 46 types of mucosal human papillomaviruses (HPV). These probes recognize the variable region comprised between the 2 conserved regions of the published GP5+/GP6+ set of PCR primers. The example described in this application, called NML Luminex genotyping method, uses a multiplex assay based on nested PCR amplification and the Luminex xMAP technology. The 46 probes have been shown to hybridize, as intended, to the DNA derived from the following HPV types: 6, 11, 13, 16, 18, 26, 30, 31, 32, 33,, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 62, 66, 67, 68, 69, 70, 71, 72, 73, 74, 81, 82, 83, 84, 85, 86, 87, 89, 90, 91 and 97. The hybridization of each probe is specific for each type without any cross hybridization among types and it is sensitive enough to allow detection of PCR products for genotyping of HPV DNA contained in clinical samples. We also present a validation of the NML Luminex method against direct sequencing of HPV types and against the Roche Linear Array, a leading commercial method for HPV genotyping. The probes described here are suitable for use in other assays based on hybridization with labelled target HPV DNA, including, but not limited to, Southern and Northern blots, reverse line blot hybridization, DNA microarray, or ELISA.
priorityDate 2010-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447502780
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407515437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199858
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID61971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451486588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6379
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID61971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460005
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA4IP64
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10566

Total number of triples: 27.